# Mammography Market

> Mammography Market Research Report: Size, Share, Trend Analysis By Types (Screening Mammography and Diagnostic Mammography), By Technology (2-D Technology, 3-D Technology, and Combination Technology), By Product (Digital Systems, Analog Systems, Breast Tomosynthesis, Film Screen Systems, and Others), By End-User (Hospitals, Specialty Clinics, Research Institutes, Diagnostic Center, and Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 9.25%
- **2024:** $ 2,982.58 Million
- **2025:** $ 3,258.53 Million
- **2035:** $ 7,894.35 Million
- **Key Players:** Companies such as Hologic (US), Siemens Healthineers (DE), GE Healthcare (US), Philips (NL), Fujifilm (JP), Canon Medical Systems (JP), Agfa HealthCare (BE), Carestream Health (US), Konica Minolta (JP) are some of the major participants in the market.

**Report ID:** MRFR/MED/1810-HCR · **Pages:** 95 · **Author:** Satyendra Maurya & Rahul Gotadki · **Last Updated:** June 05, 2026

**URL:** https://www.marketresearchfuture.com/reports/mammography-market-2443

---

## Market Summary

## **Mammography Market Overview**

As per MRFR analysis, the Mammography Market Size was estimated at 2.98 (USD Billion) in 2024.

The Mammography Market Industry is expected to grow from 3.26 (USD Billion) in 2025 to 7.23 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 9.25% during the forecast period (2025 - 2034).The increasing prevalence of breast cancer, increasing demand for early-stage diagnosis amongst patients, high R&D investments in breast cancer treatments, and expansions in breast imaging modalities are the key market drivers enhancing the market growth.A pioneer in GPT AI assistance for mammography quality, intelliMaven will go on sale in 2024, according to Densitas, a leading global provider of AI solutions for breast cancer screening.

IntelliMaven, in conjunction with Densitas' flagship product intelliMammo, offers mammography facilities scalable and long-lasting quality assurance to satisfy ACR accreditation standards and FDA MQSA EQUIP compliance. Densitas is transforming the way technologists hone their skills in an industry first. According to the unique training requirements and learning path of every techie, intelliMaven provides customized advice

Source Secondary Research, Primary Research, _Market Research Future_ Database, and Analyst Review

This week at the annual radiology and medical imaging conference, RSNA 2023, in Chicago, GE HealthCare unveiled a new AI suite. The new tool, known as the MyBreastAI suite, is intended to make radiologists' tasks easier and assist them in identifying breast cancer. The FDA has approved and approved Hologic's Genius artificial intelligence (AI) software for tomosynthesis-based early breast screening in 2020. The program is currently available for purchase. The Hologic 3D Mammography system is the operating system for the computer-aided detection (CAD) software.

The business released a statement claiming that Genius AI is the only CAD program that works with its most sophisticated packages for breast tomosynthesis, Clarity HD and 3DQuorum imaging technology.

In December 2023, MammogramNow, a first-of-its-kind screening mammography service by RadNet, Inc. to go live at the Milford Walmart Supercenter in Delaware, is introduced.

For example, in November 2023, GE HealthCare unveiled the MyBreastAI suite during the RSNA 2023 Chicago conference. The AI-driven system’s goal is to optimize radiologists’ workflow and help them diagnose breast cancer in its early stages. These technological innovations in mammography influence the demand for mammography films.

Siemens Healthineers released the Mammomat B.brilliant1 with wide-angle tomosynthesis in September 2023. The advanced mammography system is built around a wide 50° angle for tomosynthesis -the largest available on the market – which enables rapid generation of high-depth resolution images via a scan time of about five seconds.

GE Healthcare also introduced three global innovations in May 2023. These include Intelligent Radiation Therapy (IRT), Auto Segmentation, and an updated Magnetic Resonance (MR) Radiation Therapy Suite (AIR Open Coil Suite). These were showcased at the ESTRO 2023 Congress, European Society for Therapeutic Radiology and Oncology. They have been designed to support healthcare providers so that they can deliver highly-personalized care by creating access to diagnostics, technologies and crucial information upon which their decisions are based confident enough with the hope of assisting patients to lead healthy lives.

Siemens Healthineers’ manufacturing facility expansion was announced in June 2023. In relation to this plan, as it has set up its new production line (plant) for Computed Tomography Scanners at its Bengaluru site, the company aimed to boost the growth of medical devices area within India.

The Merit Health Woman’s Hospital underwent installation of a new specimen imaging center using 3D Tomosynthesis technology specifically meant for breast tissue specimens in May 2022 for better visualization of tumors during lumpectomy surgeries.

## **Mammography Market Trends**

Market CAGR for mammography is driven by the rising incidence of breast cancer in developed and developing countries. This rising incident has increased the demand for technologically advanced instruments focusing on early detection. The growing number of breast cancer patients has pushed governments across the globe to increase awareness regarding the significance of the early detection of breast cancer. As per the American Cancer Society, breast cancer is the second largest cause of cancer-related deaths in women across the world.

Around 2,261,419 new breast cancer cases were diagnosed in women, and 684,996 women died due to breast cancer worldwide in 2020.

Favorable initiatives for breast cancer screening or an increase in the number of breast cancer screening programs or campaigns are expected to boost the growth of the  mammography market. For instance, in October 2020, the Kao Group of Japan launched the 'Kao Group Pink Ribbon Campaign 2020' in prominent cities across Japan. The campaign has been operating since 2007 to convey the significance of early detection of breast cancer to as multiple people as possible. Breast cancer is presently the most common type of cancer in Japanese females, driving the growth of the mammography market revenue.

The rising incidence of breast cancer is creating a higher demand for mammography as it is an essential screening element for early detection and diagnosis. The need for timely and accurate breast cancer detection is driving the growth of the mammography market. Governments and healthcare organizations are implementing breast cancer screening programs and awareness campaigns to promote early detection and reduce breast cancer-related mortality. These initiatives and reimbursement policies drive the demand for mammography services and contribute to market growth. Increasing healthcare expenditure in many countries and improved access to healthcare services are boosting the demand for mammography.

Investments in healthcare infrastructure, advancements in medical technology, and growing disposable incomes support the market's growth.

Advancements in technology and computer programming have led to an increased involvement of computer-automated analyses in medical image interpretation. This is driven by the need for more accurate and efficient workflows in imaging interpretation. In breast imaging, FDA-approved artificial intelligence (AI) algorithms are employed to support radiologists. AI automatically scans all breast photos, identifying regions of interest that may include suspicious malignancies, driving the market growth.

## **Mammography Market Segment Insights**

### **Mammography Type Insights**

The mammography market segmentation, based on type, includes screening mammography and diagnostic mammography. The diagnostic mammography segment dominated the market, accounting for 35% of market revenue (0.96 Billion). In developing economies, segment growth is driven by the presence of skilled and experienced healthcare professionals who can provide high-quality diagnostic services. However, screening mammography is the fastest-growing category due to the expansion in the screening procedure.

### **Mammography Technology Insights**

The mammography market segmentation, based on technology, includes 2-D technology, 3-D technology, and combination technology. The 3-D technology category generated the most income (70.4%) owing to technological benefits, including the ability to manage bigger procedure volumes, increased breast cancer detection rates, and a more advantageous reimbursement scenario. However, combination technology is the fastest-growing category due to its superior depiction of low-contrast things, more comprehensive dynamic change, and improved diagnostic quality of images.

### **Mammography Product Insights**

The mammography market segmentation, based on product, includes digital systems, analog systems, breast tomosynthesis, film screen systems, and others. The breast tomosynthesis category generated the most income as digital breast tomosynthesis is a high-resolution limited-angle tomography advancement that utilizes X-rays to develop a 3-dimensional breast image. However, the digital system is the fastest-growing category owing to its superior depiction of low-contrast objects, wider dynamic change, and expanded diagnostic quality of images.

### **Mammography End-User Insights**

The mammography market segmentation, based on end-user, includes hospitals, specialty clinics, research institutes, diagnostic centers, and others. The diagnostic center category generated the most income due to increased awareness about breast cancer. However, hospitals are the fastest-growing category due to the existence of mammography facilities within a hospital can positively affect numerous factors, such as duration of hospital stay, quality of care, total healthcare cost, and availability of emergency care.

**Figure 1 Mammography Market, by Distribution Channel, 2022 & 2032 (USD Billion)**

**_Source Secondary Research, Primary Research, MRFR Database, and Analyst Review_**

**Mammography Regional Insights**

By region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North American mammography market will dominate owing to high R&D investments in breast cancer therapies, an enhanced prevalence of breast cancer, and developments in breast imaging modalities that will boost the market growth in this region. Further, the German mammography market held the largest market share, and the UK mammography market was the fastest-growing market in the North American region.

Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

**Figure 2 MAMMOGRAPHY MARKET SHARE BY REGION 2022 (USD Billion)**

**_Source Secondary Research, Primary Research, MRFR Database, and Analyst Review_**

Europe's mammography market accounts for the second-largest market share due to the availability of the most delinquent mammography systems, improved healthcare facilities, increased healthcare expenditure, and rising per capita income. Further, the German mammography market held the largest market share, and the UK mammography market was the fastest-growing market in the European region.

The Asia-Pacific mammography market is expected to grow at the fastest CAGR from 2023 to 2032. This is due to the presence of well-established healthcare facilities, and increasing awareness about the importance of early diagnosis of breast cancer will boost the market growth. Moreover, China’s mammography market held the largest market share, and the Indian mammography market was the fastest-growing market in the Asia-Pacific region.

**Mammography Key Market Players & Competitive Insights**

Key market players are supporting heavily R&D to extend their product lines, which will support the mammography market growth even more. Market participants are also undertaking multiple strategic activities to enhance their footprint ly, with important market developments such as new product launches, consolidations and acquisitions, higher investments, contractual agreements, and collaboration with other enterprises. To enhance and survive in a more competitive and rising market climate, the mammography industry must deliver cost-effective items.

Manufacturing locally to minimize operational prices is one of the major business tactics manufacturers utilize in the mammography industry to benefit clients and increase the market sector. Major players in the Mammography market, including Canon Inc., FUJIFILM Holdings Corporation, GENERAL MEDICAL ITALIA, Siemens Healthcare, Villa Systems Medical SpA, and others, are attempting to enhance market demand by investing in research and development operations.

Fujifilm Corp is a provider of imaging and information solutions. The company's product portfolio includes optical devices, digital cameras, photographing sensitive materials, functional films, imaging sensor materials, graphic systems, recording media, touchscreen panel materials, nutritional supplement products, hair care products, X-ray imaging devices, ultrasound devices, interchangeable lenses for digital cameras, electronic materials and industrial products, and office printers. Fujifilm business products include medical systems, graphic systems, optical devices, recording media, industrial products, display materials, and inkjets. It sells its products to individual consumers and business enterprises.

In October 2021, FUJIFILM Canada Inc. received a Health Canada medical device license for its ASPIRE Cristalle digital mammography solution. It also expanded its partnership with Christie Innomed to offer the product across every province in Canada.​

Hologic Inc manufactures, develops, and supplies diagnostic products, medical imaging systems, and surgical products. It delivers products that aid the diagnosis of human diseases, GYN surgical products, breast imaging, and related products and accessories, such as endometrial ablation systems and hysteroscopic tissue removal systems, and skeletal health products, including mini C-arm imaging products, and dual-energy X-ray bone densitometry systems. The firm offers solutions to surgeons, clinical laboratories, hospitals, and healthcare providers. Hologic delivers its products and services via direct deals and a network of independent distributors and sales agents. In December 2020, Hologic Inc. proclaimed U.S.

FDA approval for its Genius AI Detection technology, a unique deep learning-based software developed to aid radiologists in noticing subtle potential cancers in breast tomosynthesis images.

**Key Companies in the Mammography market include**

### Mammography Market Industry Developments

- **Q2 2024: Siemens Healthineers launches Mammomat B.smart, a new digital mammography system** Siemens Healthineers announced the launch of Mammomat B.smart, a new digital mammography system designed to improve workflow efficiency and image quality for breast cancer screening and diagnostics.
- **Q2 2024: Hologic Receives FDA Approval for 3DQuorum Imaging Technology for Mammography** Hologic announced that its 3DQuorum Imaging Technology, which uses artificial intelligence to enhance mammography image quality and reduce reading time, received FDA approval for clinical use in the United States.
- **Q2 2024: GE HealthCare acquires AI breast imaging startup iCAD for $200 million** GE HealthCare completed the acquisition of iCAD, a company specializing in artificial intelligence solutions for breast cancer detection, to expand its digital mammography and AI portfolio.
- **Q3 2024: Fujifilm launches new Aspire Cristalle mammography system in Europe** Fujifilm announced the European launch of its Aspire Cristalle mammography system, featuring advanced tomosynthesis technology for improved breast cancer detection.
- **Q3 2024: Siemens Healthineers partners with RadNet to deploy AI-powered mammography solutions** Siemens Healthineers entered a partnership with RadNet, a leading provider of outpatient imaging services, to deploy AI-powered mammography solutions across RadNet's U.S. imaging centers.
- **Q3 2024: Hologic opens new mammography manufacturing facility in Massachusetts** Hologic inaugurated a new manufacturing facility in Massachusetts dedicated to the production of advanced mammography systems, aiming to meet growing demand for breast cancer screening technologies.
- **Q4 2024: Philips receives CE mark for new AI-enabled mammography workstation** Philips announced that its new AI-enabled mammography workstation received CE mark approval, allowing for commercial distribution in the European Union.
- **Q4 2024: Volpara Health raises $30 million in Series C funding to expand AI mammography software** Volpara Health secured $30 million in Series C funding to accelerate the development and global rollout of its AI-powered mammography software for breast cancer risk assessment.
- **Q1 2025: Siemens Healthineers announces partnership with Breast Cancer Now for UK screening program** Siemens Healthineers partnered with Breast Cancer Now to provide advanced digital mammography systems for a new UK national breast cancer screening initiative.
- **Q1 2025: Hologic wins $50 million contract to supply mammography systems to U.S. Department of Veterans Affairs** Hologic was awarded a $50 million contract to supply its mammography systems to the U.S. Department of Veterans Affairs for use in VA medical centers nationwide.
- **Q2 2025: GE HealthCare launches new Pristina Mammography System with AI-based workflow** GE HealthCare introduced the Pristina Mammography System, featuring AI-based workflow enhancements designed to improve patient comfort and diagnostic accuracy.
- **Q2 2025: Fujifilm receives FDA clearance for new digital breast tomosynthesis system** Fujifilm announced FDA clearance for its new digital breast tomosynthesis system, enabling advanced 3D imaging for breast cancer screening in the U.S.

GE HealthCare launched three new worldwide innovations: Intelligent Radiation Therapy (IRT), Auto Segmentation, and an upgraded Magnetic Resonance (MR) Radiation Therapy Suite (AIR Open Coil Suite), demonstrating the company's commitment to improving the radiation oncology treatment pathway.

## **Mammography Market Segmentation**

### **Mammography Type Outlook**

### **Mammography Technology Outlook**

### **Mammography Product Outlook**

### **Mammography End-User Outlook**

**Mammography Regional Outlook**

## Market Drivers

### Market Trends and Projections

The Global Mammography Market Industry is projected to maintain a steady trajectory, with a value of 2.98 USD Billion from 2024 to 2035. The compound annual growth rate (CAGR) for this period is estimated at 0.0%, suggesting a stabilization in market dynamics.
 
Factors such as technological advancements, increased awareness, and government initiatives are expected to contribute to this stability. However, the market may also face challenges, including economic fluctuations and varying healthcare policies across different regions. Overall, the market appears poised for a consistent yet cautious growth phase.

- World Bank health expenditure data show sustained global investment in healthcare systems, with healthcare spending exceeding 10% of global GDP in recent years. Continued investment in diagnostic infrastructure, preventive screening, and women's health programs supports long-term demand for mammography technologies worldwide.

### Rising Incidence of Breast Cancer

The rising incidence of breast cancer globally is a significant factor propelling the Global Mammography Market Industry. Statistics indicate that breast cancer remains one of the most common cancers among women worldwide. This alarming trend has prompted healthcare providers to emphasize the importance of regular mammography screenings.
 
As awareness of breast cancer risks increases, more women are seeking preventive care. This growing demand for screening services is likely to sustain the market's value at 2.98 USD Billion through 2035, indicating a persistent need for effective diagnostic tools.

- IHME data identify breast cancer as one of the leading contributors to cancer burden among women globally. The increasing prevalence of breast cancer and expanding screening recommendations are driving demand for advanced mammography systems that facilitate early detection and improved disease management.

### Government Initiatives and Funding

Government initiatives aimed at improving breast cancer screening are significantly influencing the Global Mammography Market Industry. Many nations are allocating funds to enhance access to mammography services, particularly in underserved regions.
 
For example, public health policies are increasingly mandating insurance coverage for routine screenings, which encourages more women to participate. These efforts are crucial in reducing disparities in healthcare access and ensuring that women receive timely screenings. As a result, the market is likely to remain stable, with a projected value of 2.98 USD Billion from 2024 to 2035.

- World Bank indicators highlight increasing public healthcare expenditures across multiple countries, supporting national cancer screening programs and preventive healthcare initiatives. These investments improve access to mammography services and encourage broader participation in breast cancer screening programs.

### Increasing Awareness of Breast Cancer

The Global Mammography Market Industry is experiencing growth due to heightened awareness surrounding breast cancer. Educational campaigns and initiatives by health organizations have led to increased screening rates. For instance, in many countries, public health programs are promoting regular mammography screenings, particularly for women aged 40 and above.
 
This awareness is crucial as early detection significantly improves treatment outcomes. As a result, the market is projected to maintain a value of 2.98 USD Billion in 2024, reflecting the importance of proactive health measures in combating breast cancer.

- PubMed research demonstrates that organized awareness campaigns and population-based screening programs significantly increase mammography participation rates. Enhanced public awareness regarding early detection benefits continues to support utilization of mammography technologies and breast cancer screening services.

### Technological Advancements in Imaging

Technological innovations in mammography equipment are driving the Global Mammography Market Industry forward. The introduction of digital mammography and 3D tomosynthesis has enhanced image quality and diagnostic accuracy. These advancements allow for better detection of abnormalities, which is vital for effective treatment planning.
 
Furthermore, the integration of artificial intelligence in mammography systems is streamlining workflows and improving patient outcomes. As these technologies become more widely adopted, they are expected to sustain the market's value at 2.98 USD Billion through 2035, indicating a stable yet evolving landscape.

- PubMed studies report that digital mammography, tomosynthesis, and AI-assisted image interpretation improve lesion detection rates and diagnostic accuracy. Continued innovation in breast imaging technologies is supporting stronger clinical outcomes and expanding adoption of advanced mammography platforms.

### Aging Population and Increased Screening

The aging population is a critical driver for the Global Mammography Market Industry. As life expectancy rises, the number of women at risk for [breast cancer](https://www.marketresearchfuture.com/reports/global-breast-cancer-market-1379) increases, necessitating regular screenings. Older women are more likely to develop breast cancer, which underscores the importance of mammography in this demographic.
 
Consequently, healthcare systems are adapting to meet the growing demand for screening services. This trend suggests that the market will maintain its value at 2.98 USD Billion in 2024, reflecting the ongoing need for effective breast cancer detection strategies.

- IHME demographic analyses indicate a steadily growing population aged 50 years and above, a key demographic at elevated breast cancer risk. Increasing aging populations globally continue to support demand for routine screening programs and advanced mammography equipment.

## Future Outlook

The Mammography Industry size is projected to reach USD 7894.35 Million by 2035, growing at a CAGR of 9.25%, driven by technological advancements, increasing awareness, and rising healthcare expenditures.

**New opportunities:**

- Expansion of telemammography services for remote diagnostics. Development of AI-driven imaging software to enhance accuracy. Partnerships with healthcare providers for mobile mammography units.

By 2035, the Mammography Market is expected to be robust, driven by innovation and strategic partnerships.

## Segment Insights

### By Application: Screening (Largest) vs. Diagnostic (Fastest-Growing)

In the Mammography Market, the application segment is characterized by distinct uses, including Screening, Diagnostic, Research, and Therapeutic. Among these, the screening application holds the largest market share of 49%, driven by its widespread use in early detection and preventive care. Diagnostic applications follow closely, accounting for a significant portion of the market, while Research and Therapeutic applications are smaller but play crucial roles in the advancement of mammography technology.

Hologic continues supporting breast cancer screening initiatives through advanced mammography platforms and breast tomosynthesis technologies. Screening accounted for approximately 49% of the Mammography Market in 2024, driven by growing preventive healthcare programs and increasing emphasis on early breast cancer detection worldwide.

### By Technology: Digital Mammography (Largest) vs. 3D Mammography (Fastest-Growing)

The Mammography Market has seen a significant distribution of market share across its technological segments. Digital Mammography holds the largest share of 46%, driven by its advanced imaging capabilities and greater accuracy compared to traditional methods. In contrast, Analog Mammography continues to hold a portion of the market, primarily appealing to facilities that prefer lower initial costs. However, segments like 3D Mammography are rapidly gaining traction due to their innovative approach to breast screening, providing better detection rates and enhanced visualization of breast tissues. As the demand for early detection and accurate diagnostic tools increases, 3D Mammography is emerging as the fastest-growing segment in the Mammography Market. This growth is influenced by technological advancements, increased awareness about breast cancer, and the introduction of government initiatives promoting regular screening. Furthermore, Breast MRI is also witnessing growth due to its non-invasive nature and ability to provide detailed imaging for complex cases, thus complementing traditional mammography methods effectively.

Siemens Healthineers continues expanding its digital imaging portfolio through advanced mammography solutions and AI-enabled diagnostics. Digital Mammography represented approximately 46% market share in 2024, supported by superior image quality, workflow efficiency, and widespread clinical adoption across healthcare facilities.

### By End User: Hospitals (Largest) vs. Diagnostic Imaging Centers (Fastest-Growing)

In the Mammography Market, the distribution of market share among end users is predominantly led by hospitals, which remain the largest segment and holding market share of 58% due to their extensive resources and established patient base. Diagnostic imaging centers follow closely behind, gaining traction as specialized facilities which are pivotal in offering advanced diagnostic services tailored to women's health. Specialty clinics and research institutions represent smaller segments but contribute valuable insights and innovations to the market landscape. Growth trends within the end-user segment are primarily driven by increasing awareness of breast cancer and the importance of early detection. Hospitals continue to invest in advanced imaging technologies, enhancing their capabilities. Meanwhile, diagnostic imaging centers are benefiting from a rise in demand for outpatient services and personalized patient care, positioning them for rapid growth in the foreseeable future.

Hospitals: Dominant vs. Diagnostic Imaging Centers: Emerging

Hospitals play a dominant role in the Mammography Market, primarily due to their comprehensive healthcare services and robust infrastructure, which facilitate the integration of mammography into routine women's health screenings. They often have the ability to offer both inpatient and outpatient services, which broadens their patient reach. However, diagnostic imaging centers are emerging as a significant player, particularly as the demand for specialized care and outpatient procedures rises. These centers focus on providing personalized care and reducing wait times, thus appealing to a growing demographic. Their ability to harness advanced technology and streamline processes is pivotal for their expansion, making them a critical aspect of the mammography market's evolution.

### By Product Type: Mammography Systems (Largest) vs. Mammography Software (Fastest-Growing)

In the Mammography Market, the distribution of market share among product types reveals that Mammography Systems hold the largest segment and market share of 64%, significantly surpassing the other categories in terms of revenue and utilization in healthcare settings. This dominance is attributed to the widespread adoption of advanced mammography technologies, such as digital and 3D mammography systems, which provide superior imaging quality and improved diagnostic accuracy. Meanwhile, Mammography Software is rapidly gaining traction, driven by the increasing need for enhanced data management, patient tracking, and integration with existing hospital information systems.

Mammography Systems (Dominant) vs. Mammography Software (Emerging)

Mammography Systems are characterized by their pivotal role in breast cancer screening and diagnosis, making them the dominant force in the market. Their technological advancements enhance detection rates and patient outcomes, resulting in substantial endorsements from healthcare professionals. In contrast, Mammography Software is seen as an emerging player, with a focus on streamlining workflows and improving diagnostic efficiency through intelligent data analysis and machine learning. The software segment is expected to evolve rapidly as hospitals increasingly prioritize digitalization. Together, these segments showcase a complementary relationship, where systems bolster imaging capabilities while software optimizes operational efficiency.

### By Patient Demographics: Age Group (Largest) vs. Gender (Fastest-Growing)

In the Mammography Market, the distribution of patient demographics reveals that the age group segment commands the largest market share of 68%. Typically, women aged 40 and above tend to constitute a significant proportion of mammography screenings due to the increased risk of breast cancer associated with age. This demographic underpins the bulk of healthcare spending and screening programs, making it crucial for market participants to target this group effectively. In contrast, gender representation in mammography is witnessing a paradigm shift as awareness campaigns and health initiatives focus more on male susceptibility to breast cancer, thus driving growth in the male demographics seeking screenings.

Age Group: 40+ (Dominant) vs. Gender: Male (Emerging)

The age group of 40 and above is currently dominant in the Mammography Market. This cohort not only represents the bulk of screening activities but is also targeted by healthcare providers due to heightened awareness and preventative measures. The increasing prevalence of breast cancer in older women emphasizes the need for regular screenings. Meanwhile, the male demographic finds itself as an emerging segment within this market, spurred by advancements in cancer awareness efforts that extend to men. As initiatives evolve, there is a growing recognition of male breast cancer risk, positioning this segment as a notable area for growth and outreach in the years to come.

## Regional Market Share Analysis

### North America : Market Leader in Innovation

North America leads in the Mammography Market Size, accounting for over 50.00% of the global revenue in 2024. The growth is driven by increasing awareness of breast cancer screening, advancements in imaging technology, and supportive healthcare policies. Regulatory bodies are promoting early detection initiatives, which further fuels demand for mammography services and equipment. The region's robust healthcare infrastructure and high disposable income also contribute to its market dominance.

- CDC statistics indicate that breast cancer remains one of the most frequently diagnosed cancers among women in the United States, with more than 240,000 new invasive cases reported annually. The continued focus on early detection and screening programs supports strong demand for mammography systems throughout North America.

The competitive landscape in North America is characterized by the presence of major players such as Hologic, GE Healthcare, and Siemens Healthineers. These companies are at the forefront of innovation, offering advanced mammography systems that enhance diagnostic accuracy. The U.S. remains the largest market, with Canada also showing promising growth. The focus on personalized healthcare and technological advancements positions North America as a key player in The Mammography.

- GE Healthcare continues investing in advanced breast imaging technologies, AI-enabled mammography solutions, and diagnostic innovation. These developments support healthcare providers in improving screening accuracy, expanding access to breast cancer detection services, and strengthening North America's leadership in mammography adoption.

### Europe : Emerging Market with Growth Potential

Europe Mammography Market size was valued at USD 850 Million in 2024, making it the second-largest regional market with a 28.50% share., reflecting a growing emphasis on breast cancer screening and early detection. The region benefits from stringent regulations and guidelines that promote regular screening, which is crucial for improving patient outcomes. Countries like Germany and France are leading the charge, supported by government initiatives aimed at increasing awareness and accessibility of mammography services. The integration of digital technologies is also enhancing the efficiency of screening processes.

- The European Medicines Agency (EMA) supports regulatory frameworks that encourage innovation in diagnostic technologies and cancer detection solutions. Growing implementation of national screening programs, combined with strong healthcare infrastructure, continues to support increased mammography utilization across European healthcare systems.

Leading countries in Europe include Germany, France, and the UK, where key players like Siemens Healthineers and Philips are making significant contributions. The competitive landscape is evolving, with a focus on innovative solutions that cater to diverse patient needs. The presence of established healthcare systems and funding for advanced technologies further strengthens the market. As stated by the European Commission, "The implementation of national screening programs is essential for reducing breast cancer mortality rates."

### Asia-Pacific : Rapidly Growing Market

The Asia-Pacific mammography market, valued at 500.0 million, is witnessing rapid growth driven by rising awareness of breast cancer and the importance of early detection. Countries like Japan and Australia are leading the market, supported by government initiatives that promote regular screening. The increasing prevalence of breast cancer in the region is prompting healthcare providers to invest in advanced mammography technologies, thereby enhancing service delivery and patient outcomes.

The competitive landscape in Asia-Pacific is characterized by the presence of key players such as Fujifilm and Canon Medical Systems. These companies are focusing on expanding their product offerings and enhancing technological capabilities to meet the growing demand. The region's diverse healthcare systems and varying levels of access to screening services present both challenges and opportunities for market players. The emphasis on improving healthcare infrastructure is expected to further drive market growth.

### Middle East and Africa : Emerging Market with Challenges

The Middle East and Africa mammography market is valued at 141.29 million, reflecting a growing focus on healthcare development and breast cancer awareness. The region faces challenges such as limited access to screening facilities and varying levels of healthcare infrastructure. However, increasing government initiatives aimed at improving healthcare access and awareness are driving demand for mammography services. The rising incidence of breast cancer is prompting stakeholders to invest in screening technologies and programs. Leading countries in this region include South Africa and the UAE, where key players like Agfa HealthCare and Carestream Health are making strides.

The competitive landscape is evolving, with a focus on partnerships and collaborations to enhance service delivery. As healthcare systems develop, the potential for growth in the mammography market is significant, supported by a commitment to improving patient outcomes and access to care. The World Health Organization emphasizes the importance of early detection in reducing breast cancer mortality rates.

## Competitive Benchmarking

The Mammography Market is currently characterized by a dynamic competitive landscape, driven by technological advancements, increasing awareness of breast cancer screening, and a growing emphasis on early detection. Major players such as Hologic (US), Siemens Healthineers (DE), and GE Healthcare (US) are at the forefront, each adopting distinct strategies to enhance their market presence. Hologic (US) focuses on innovation in breast imaging technologies, particularly through the development of 3D mammography systems, which have been shown to improve detection rates. Siemens Healthineers (DE) emphasizes partnerships and collaborations to expand its product offerings and enhance service delivery, while GE Healthcare (US) is investing heavily in digital transformation to streamline operations and improve patient outcomes.
 
Collectively, these strategies contribute to a competitive environment that is increasingly centered on technological innovation and strategic partnerships.In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The market structure appears moderately fragmented, with several key players holding substantial market shares, yet numerous smaller firms also contributing to the competitive dynamics. This fragmentation allows for a diverse range of products and services, catering to varying customer needs and preferences.
 
In November Hologic (US) announced the launch of its latest 3D mammography system, which integrates advanced AI capabilities to assist radiologists in interpreting images more accurately. This strategic move is likely to enhance Hologic's competitive edge by addressing the growing demand for precision in breast cancer screening, thereby potentially increasing its market share. The integration of AI not only improves diagnostic accuracy but also streamlines workflow, which is crucial in high-volume clinical settings.
 
In October Siemens Healthineers (DE) entered into a strategic partnership with a leading telehealth provider to enhance remote diagnostic capabilities for mammography. This collaboration is indicative of a broader trend towards digital health solutions, allowing for improved access to screening services, particularly in underserved regions. By leveraging telehealth, Siemens Healthineers (DE) positions itself as a forward-thinking player in the market, likely increasing its appeal to healthcare providers seeking comprehensive solutions.
 
In September GE Healthcare (US) unveiled a new initiative aimed at sustainability in its manufacturing processes, focusing on reducing carbon emissions and waste associated with mammography equipment production. This initiative not only aligns with global sustainability goals but also resonates with healthcare providers increasingly prioritizing environmentally friendly practices. GE Healthcare's commitment to sustainability may enhance its brand reputation and attract customers who value corporate responsibility.
 
As of December the Mammography Market is witnessing trends such as digitalization, AI integration, and a heightened focus on sustainability. Strategic alliances are becoming increasingly pivotal, as companies recognize the need to collaborate to enhance their technological capabilities and market reach. The competitive differentiation is likely to evolve from traditional price-based competition towards a landscape where innovation, technology, and supply chain reliability are paramount. This shift suggests that companies that prioritize these aspects will be better positioned to thrive in the future.

## Recent News & Developments

- [FDA’s Mammography Quality Standards Act](https://www.fda.gov/radiation-emitting-products/mammography-quality-standards-act-mqsa-and-mqsa-program) (MQSA) requires mammography facilities to be FDA-certified, meet quality standards, and provide every patient with a written, easy-to-understand report of their mammogram results, including prompt notification if findings are suspicious.
- **Q2 2024: Siemens Healthineers launches Mammomat B.smart, a new digital mammography system** Siemens Healthineers announced the launch of Mammomat B.smart, a new digital mammography system designed to improve workflow efficiency and image quality for breast cancer screening and diagnostics.
- **Q2 2024: Hologic Receives FDA Approval for 3DQuorum Imaging Technology for Mammography Market** Hologic announced that its 3DQuorum Imaging Technology, which uses artificial intelligence to enhance mammography image quality and reduce reading time, received FDA approval for clinical use in the United States.
- **Q2 2024: GE HealthCare acquires AI breast imaging startup iCAD for $200 million** GE HealthCare completed the acquisition of iCAD, a company specializing in artificial intelligence solutions for breast cancer detection, to expand its digital mammography and AI portfolio.
- **Q3 2024: Fujifilm launches new Aspire Cristalle mammography system in Europe** Fujifilm announced the European launch of its Aspire Cristalle mammography system, featuring advanced tomosynthesis technology for improved breast cancer detection.
- **Q3 2024: Siemens Healthineers partners with RadNet to deploy AI-powered mammography solutions** Siemens Healthineers entered a partnership with RadNet, a leading provider of outpatient imaging services, to deploy AI-powered mammography solutions across RadNet's U.S. imaging centers.
- **Q3 2024: Hologic opens new mammography manufacturing facility in Massachusetts** Hologic inaugurated a new manufacturing facility in Massachusetts dedicated to the production of advanced mammography systems, aiming to meet growing demand for breast cancer screening technologies.
- **Q4 2024: Philips receives CE mark for new AI-enabled mammography workstation** Philips announced that its new AI-enabled mammography workstation received CE mark approval, allowing for commercial distribution in the European Union.
- **Q4 2024: Volpara Health raises $30 million in Series C funding to expand AI mammography software** Volpara Health secured $30 million in Series C funding to accelerate the development and global rollout of its AI-powered mammography software for breast cancer risk assessment.
- **Q1 2025: Siemens Healthineers announces partnership with Breast Cancer Now for UK screening program** Siemens Healthineers partnered with Breast Cancer Now to provide advanced digital mammography systems for a new UK national breast cancer screening initiative.
- **Q1 2025: Hologic wins $50 million contract to supply mammography systems to U.S. Department of Veterans Affairs** Hologic was awarded a $50 million contract to supply its mammography systems to the U.S. Department of Veterans Affairs for use in VA medical centers nationwide.
- **Q2 2025: GE HealthCare launches new Pristina Mammography Market System with AI-based workflow** GE HealthCare introduced the Pristina Mammography Market System, featuring AI-based workflow enhancements designed to improve patient comfort and diagnostic accuracy.
- **Q2 2025: Fujifilm receives FDA clearance for new digital breast tomosynthesis system** Fujifilm announced FDA clearance for its new digital breast tomosynthesis system, enabling advanced 3D imaging for breast cancer screening in the U.S.

GE HealthCare launched three new worldwide innovations: Intelligent Radiation Therapy (IRT), Auto Segmentation, and an upgraded Magnetic Resonance (MR) Radiation Therapy Suite (AIR Open Coil Suite), demonstrating the company's commitment to improving the radiation oncology treatment pathway.

## Report Scope

| MARKET SIZE 2024 | 2982.58(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 3258.53(USD Million) |
| MARKET SIZE 2035 | 7894.35(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 9.25% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Hologic (US), Siemens Healthineers (DE), GE Healthcare (US), Philips (NL), Fujifilm (JP), Canon Medical Systems (JP), Agfa HealthCare (BE), Carestream Health (US), Konica Minolta (JP) |
| Segments Covered | Application, Technology, End User, Product Type, Patient Demographics |
| Key Market Opportunities | Integration of artificial intelligence in Mammography Market enhances diagnostic accuracy and efficiency. |
| Key Market Dynamics | Technological advancements in imaging techniques drive competition and enhance early detection capabilities in the mammography market. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the current valuation of the Mammography Market as of 2024?**
A: The Mammography Market was valued at approximately 2982.58 USD Million in 2024.

**Q: What is the projected market valuation for the Mammography Market in 2035?**
A: The market is projected to reach approximately 7894.35 USD Million by 2035.

**Q: What is the expected CAGR for the Mammography Market during the forecast period 2025 - 2035?**
A: The expected CAGR for the Mammography Market during the forecast period 2025 - 2035 is 9.25%.

**Q: Which companies are considered key players in the Mammography Market?**
A: Key players in the Mammography Market include Hologic, Siemens Healthineers, GE Healthcare, Philips, Fujifilm, Canon Medical Systems, Carestream Health, Agfa HealthCare, and Konica Minolta.

**Q: What are the main application segments of the Mammography Market?**
A: The main application segments include Screening, Diagnostic, Research, and Therapeutic, with Screening valued at 1200.0 USD Million in 2024.

**Q: How does the market size for Digital Mammography compare to Analog Mammography?**
A: In 2024, Digital Mammography was valued at 1190.0 USD Million, whereas Analog Mammography was valued at 600.0 USD Million.

**Q: What is the market valuation for 3D Mammography as of 2024?**
A: The market valuation for 3D Mammography was approximately 800.0 USD Million in 2024.

**Q: Which end-user segments are driving the Mammography Market?**
A: The end-user segments driving the market include Hospitals, Diagnostic Imaging Centers, Specialty Clinics, and Research Institutions, with Hospitals valued at 1190.79 USD Million in 2024.

**Q: What is the projected growth for the Diagnostic segment of the Mammography Market by 2035?**
A: The Diagnostic segment is projected to grow from 800.0 USD Million in 2024 to approximately 2100.0 USD Million by 2035.

**Q: How does the Therapeutic segment's valuation change from 2024 to 2035?**
A: The Therapeutic segment is expected to increase from 582.58 USD Million in 2024 to around 1594.35 USD Million by 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/mammography-market-2443*